Avant Diagnostics Announces Data Presentations at

Avant Diagnostics Announces Data Presentations at 2016 ASCO Annual Meeting

POSTER PRESENTATION #1
Sunday June 5, 8:00 AM – 11:30 AM CT

Abstract #558: Reverse-phase protein microarray (RPPA) analysis of PD-L1 and growth factor receptor signal transduction pathways in hormone receptor (HR)-positive primary breast cancer tissue and correlation with relapse.

Principle Investigator: Alan Lipton, MD, Penn State Hershey Medical Center
Presenter: Suhail M. Ali, MD, MBBS, Penn State Hershey Medical Center, VA Medical Center
Session: Breast Cancer-HER2/ER
Poster Display: Hall A; Poster Board 46; 8:00 AM – 11:30 AM CT

POSTER PRESENTATION #2
Monday June 6, 1:00 PM – 4:30 PM CT

Abstract # 11527: Androgen receptor activation in HER2-negative breast cancer liver metastases.

Principle Investigator: Joyce O’Shaughnessy, MD, Baylor University Center, Texas Oncology
Presenter: Corinne Ramos, Ph.D., Theranostics Health, Gaithersburg, MD
Session: Tumor Biology
Poster Display: Hall A; Poster Board 224; 1:00 PM – 4:30 PM CT

http://www.avantdiagnostics.com/news-media/pr...-2016-asco

Cheers